Study population
atrial fibrillation, atrial flutter
ATRIAL FIBRILLATION, HEART, TYPE 2 DIABETES, ATRIAL FLUTTER
In order to be eligible for the study, participants had to meet the following criteria: be at least 18 years old, have a confirmed diagnosis of type 2 diabetes, have an ejection fraction of 40% or lower, and exhibit New York Heart Association (NYHA) class II, III, or IV symptoms. Additionally, Patients were mandated to possess a plasma concentration of N-terminal pro-B-type natriuretic peptide (NT-proBNP) equal to or exceeding 600 pg per milliliter. If patients had atrial fibrillation or atrial flutter upon baseline electrocardiography, their NT-proBNP level needed to be at least 900 pg per milliliter.